Achillion Pharmaceuticals (ACHN)
Achillion Pharmaceuticals EBITDA Margin TTM: -1594%
View ACHN EBITDA Margin TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
ACHN EBITDA Margin TTM Rankings
| Overall | 0th percentile | 3820 of 3847 |
| Sector | 4th percentile | 432 of 450 in Healthcare |
| Industry | 9th percentile | 110 of 122 in Biotechnology |
ACHN EBITDA Margin TTM Range, Past 5 Years
| Minimum | -32042% | Mar 2010 |
| Maximum | 11662% | Dec 2008 |
| Average | -2641% |
About EBITDA Margin (TTM)
The EBITDA Margin is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.
Investors look at this measurement to get a closer approximation of performance of the business relative to sales before adjusting for the capital structure of the business (debt vs. equity financing).
Though many investors use EBITDA for this reason, some argue that the exclusion of depreciation expenses fails to capture the ongoing economics of a business since depreciation expenses are a good proxy for the replacement costs of property, plant and equipment, which must be paid in the future to continue business operations.
Learn More
You may also be interested in these ACHN related companies
ACHN News
$ACHN - http://stks.co/3yzI http://stks.co/3yzJ Updated chart. $7.40 trigger still intact.
about 2 days ago by Ammeo
about 2 days ago by Ammeo
$ACHN had a huge fall.....and has consolidated nicely. Should move up very well from here on its news. HF in here now too
about 6 days ago by taketheplunge
about 6 days ago by taketheplunge
News related to $ACHN, currently -5.6% since open: 'Achillion gets FDA incentives for hepatitis C drug' http://stks.co/3pmu
about 12 days ago by TradeBot
about 12 days ago by TradeBot
$ACHN up 7% in pre today but $IDIX still the better co. and both heating back up again lately while everyone distracted by $FB
about 12 days ago by QR_Winner
about 12 days ago by QR_Winner
EBR: Watchlist/worksheet/4 Trading Ideas: $OPTR $ACHN $BEAM $V http://stks.co/3pOI
about 12 days ago by TheEquitiesRoom
about 12 days ago by TheEquitiesRoom
ACH-3102 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C
May 15, 7:02AM Benzinga
May 15, 7:02AM Benzinga
@WalkenTalken nailed this $soda. For his next trick maybe he can endorse some $ACHN for me. Find out his take on $PCLN $MCP
about 18 days ago by HTB_Krull
about 18 days ago by HTB_Krull
Achillion Advances Second Generation Pan-Genotypic NS5A Inhibitor, ACH-3102, Into Clinical Development
May 09, 7:00AM GlobeNewswire
May 09, 7:00AM GlobeNewswire
$achn now green too......what is going on in hep c world? $achn $idix
about 19 days ago by taketheplunge
about 19 days ago by taketheplunge
UPDATE: UBS Investment Research Upgrades Achillion to Neutral; Balanced Risk/Reward
May 07, 12:55PM Benzinga
May 07, 12:55PM Benzinga
RT @AaronM @Bleedblue sorry about that confusion.. I heart $ARNA.. $ACHN blows < stop reading AF's columns and go long bud!>
about 26 days ago by Bleedblue
about 26 days ago by Bleedblue
Baird Maintains an 'Outperform' on Achillion Pharmaceuticals (ACHN); Reassuring Clarification on '1625
Apr 23, 2:22PM Street Insider
Apr 23, 2:22PM Street Insider
Wells Fargo Maintains an 'Outperform' on Achillion Pharmaceuticals (ACHN); A Few Hiccups, But Expect Positive N-T Data
Apr 23, 12:27PM Street Insider
Apr 23, 12:27PM Street Insider
Achillion (ACHN) Updates on EQT Data from Segment 2 of ACH-1625 Phase 2a
Apr 23, 9:27AM Street Insider
Apr 23, 9:27AM Street Insider
Pharmaceutical Companies Look to Biotech Industry to Combat Losses From Expiring Patents
Apr 23, 8:20AM Marketwire
Apr 23, 8:20AM Marketwire
JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform
Apr 23, 8:08AM Street Insider
Apr 23, 8:08AM Street Insider
Achillion (ACHN) Presents Strong Data from ACH-1625 Phase 2a; Safety Profile Similar
Apr 23, 7:36AM Street Insider
Apr 23, 7:36AM Street Insider
Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C
Apr 21, 4:00AM GlobeNewswire
Apr 21, 4:00AM GlobeNewswire
Baird Reiterates an 'Outperform' on Achillion Pharmaceuticals (ACHN); Buy on Weakness
Apr 19, 4:29PM Street Insider
Apr 19, 4:29PM Street Insider
UPDATE - UBS Initiates Coverage on Achillion Pharma (ACHN) with a Neutral; All-Oral Combo Already Priced In
Apr 12, 10:57AM Street Insider
Apr 12, 10:57AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ACHN | 7.35 | +0.03 | +0.41% | 518.69M |
| ACH | 10.07 | -0.25 | -2.42% | 1.589B |
| ACGL | 38.31 | -0.31 | -0.80% | 5.188B |
| ACG | 8.20 | +0.00 | +0.00% | |
| ACFN | 8.89 | -0.26 | -2.84% | 157.80M |
| ACFCD | 2.18 | +0.33 | +17.84% | |
| ACFC | 2.18 | +0.33 | +17.84% | |
| ACET | 8.25 | +0.03 | +0.36% | 221.10M |
| ACAS | 9.17 | -0.02 | -0.22% | 3.063B |
| ACAD | 1.46 | +0.09 | +6.57% | 77.23M |